OMNICEF

LOE Approaching

cefdinir

NDAORALCAPSULE
Approved
Dec 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
16

Clinical Trials (5)

NCT00834535Phase 1Completed

Cefdinir Capsules 300 mg, Non-fasting

Started Jul 2005
32 enrolled
Healthy
NCT00835484Phase 1Completed

Cefdinir Capsules 300 mg, Fasting

Started Jul 2005
32 enrolled
Healthy
NCT00883883Phase 1Completed

To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250 mg/5 ml Oral Suspension Fed Conditions

Started Apr 2005
40 enrolled
Healthy
NCT00882700Phase 1Completed

To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicef 300 mg Capsule Fasting Conditions

Started Apr 2005
28 enrolled
Healthy
NCT00882570Phase 1Completed

To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250mg/5 ml Oral Suspension Fasting Conditions

Started Apr 2005
40 enrolled
Healthy